Pharmacists' Perspectives on Nicotine Vaping Products (NVPs) for Smoking Cessation in Australia: A Qualitative Analysis.

David Le, Maya Saba, Habib Bhurawala, Muhammad Aziz Rahman, Smita Shah, Bandana Saini

Abstract read

In one paragraph

Article in Pharmacy (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Mapping Access to Nicotine Vaping Products for Smoking Cessation: Pharmacist Needs and Practice Implications in South-East Melbourne.Health promotion journal of Australia : official journal of Australian Association of Health Promotion Professionals · 2026
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

David LeSydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2050, Australia.ORCID 0009-0009-8871-2419

Maya SabaSydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2050, Australia.ORCID 0000-0001-5101-8882

Habib BhurawalaPaediatric Department, Nepean Hospital, Nepean Blue Mountains Local Health District, Penrith, NSW 2750, Australia.ORCID 0000-0001-5114-9380

Muhammad Aziz RahmanInstitute of Health and Wellbeing, Federation University Australia, Berwick, VIC 3806, Australia.ORCID 0000-0003-1665-7966

Smita ShahThe Woolcock Institute of Medical Research, Macquarie University, Sydney, NSW 2113, Australia.ORCID 0000-0002-7675-1834

Bandana SainiSydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2050, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vaping, particularly the use of nicotine vaping products (NVPs), has emerged as a public health concern. The regulatory environment surrounding NVPs in Australia has rapidly evolved, shifting from a prescription-only model to availability through community pharmacies. Pharmacists play a critical role in addressing vaping-related health concerns. This study explores Australian pharmacists' perspectives on their professional roles and the support needed to manage vaping-related enquiries. Qualitative semi-structured interviews were conducted with 25 practicing pharmacists using a topic guide developed from the current literature and team expertise. The interviews were transcribed verbatim and analysed thematically using an inductive approach to identify key themes. Key themes included

Indexed as

health servicesnicotine vaping products (NVPs)perceptionspharmacistssmoking cessationvaping

Identifiers

PMID39998009

DOI10.3390/pharmacy13010011

PMCPMC11858986

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.